JPET #64873 potentials typically exhibits low gain (Ca 2+ release/Ca 2+ current). In contrast, we have presented evidence that contractions activated by steps from membrane potentials near the resting potential involve a high gain mode of CICR in which very little current is required to initiate sarcoplasmic reticulum (SR) release of Ca 2+ (Ferrier et al., 2004) . Thus, the defect in contraction observed in myocytes from CM hamsters was caused by selective depression of high gain CICR (Howlett et al., 1999) .
The contribution of high gain CICR to myocyte contraction is modulated by phosphorylation through the cAMP-dependent protein kinase A (PKA) and Ca 2+ calmodulin kinase pathways (Hobai et al., 1997; Ferrier et al., 1998; Zhu and Ferrier, 2000; Ferrier and Howlett, 2003) . Modulation of high gain CICR by PKA appears to be highly compartmentalized. This was shown in experiments on guinea pig ventricular myocytes where selective phosphodiesterase III (PDE-III) inhibition by amrinone augmented high gain CICR with virtually no effect on low gain CICR, and little effect on I Ca-L (Xiong et al, 2001) . As the defect in contraction in CM myocytes is primarily linked to depression of high gain CICR, it is possible that stimulation of high gain CICR with amrinone might restore strength of contraction in myocytes from these animals.
The objectives of this study were: 1) to determine whether amrinone selectively increases high gain CICR in hamster myocytes; 2) to determine whether amrinone can reverse depression of contractile function that occurs in CM hamster myocytes prior to the onset of heart failure; 3) to determine whether the inotropic effects of amrinone in myocytes from normal and/or CM hamsters are mediated by actions on I Ca-L or SR Ca 2+ .
JPET #64873 7 transient outward current were inhibited with 200 µM lidocaine and 2 mM 4-aminopyridine, respectively. Most solutions were delivered from a reservoir at 3 ml/min and were changed by switching the inlet to the pump between different solutions. The solution exchange time was about 2 min, as determined by the response to changing extracellular K + . To assess SR Ca In all experiments, voltage clamp test steps were preceded by trains of 200 ms conditioning pulses from a holding potential of -80 mV to 0 mV delivered at approximately 3 Hz, to maintain consistent activation of the myocyte. Conditioning pulses were followed by a 500 ms long post-conditioning potential of -40 or -60 mV from which the test steps were made.
Current, voltage and contractions were measured with pClamp analysis software. Inward I Ca-L was measured as the difference between the peak inward current and a reference point near the end of the voltage step (Li et al., 1995 
RESULTS
In a previous study we demonstrated that contractions initiated from negative membrane potentials were selectively depressed in myocytes from CM hamsters (Howlett et al., 1999) . figure 1A . Following the train of conditioning pulses, the cells were clamped to a post-conditioning potential of -60 mV, followed by sequential steps to -40 and 0 mV. Figure 1B shows records of contractions and currents recorded from a myocyte from a normal heart. The test step to -40 mV initiated a phasic contraction with little accompanying inward current. The subsequent step to 0 mV elicited a second phasic contraction and activated I Ca-L . In contrast, in the CM myocyte the voltage step to -40 mV failed to elicit a contraction ( Figure 1C ). However, the voltage clamp step to 0 mV initiated a phasic contraction and I Ca-L . Figure 1D shows mean amplitudes of contractions (fractional shortening) and current densities recorded from normal and CM myocytes. The amplitudes of contractions elicited by steps to -40 mV were significantly smaller in CM compared to normal myocytes. There was no difference in the amplitudes of the accompanying small inward currents. However, the step to 0 mV elicited contractions and I Ca-L of comparable magnitudes in myocytes from normal and CM hearts. Thus, myocytes from CM hearts exhibited marked depression of contractions initiated by steps from -60 to -40 mV, with no difference in contractions initiated by steps from -40 to 0 mV.
The next series of experiments used the same voltage clamp protocol as in figure 1 to investigate the effects of amrinone on contractions and currents in myocytes from normal hamsters. Figure 2A Figure 3C ). Thus, amrinone did not restore contractions initiated by steps from negative potentials in CM myocytes. Amrinone also had no significant effect on contractions initiated by the step from -40 to 0 mV in CM myocytes. However, amrinone did significantly reduce the amplitudes of I Ca-L in CM myocytes, although this effect appeared to be slightly smaller than in normal myocytes.
It is possible that the lack of inotropic effect of amrinone on CICR initiated by steps from -40 to 0 mV in both normal and CM myocytes is related to the use of sequential activation steps.
This article has not been copyedited and formatted. The final version may differ from this version. This might occur if the first step from -60 to -40 mV partially depletes SR stores. Therefore, we examined effects of amrinone on contractions and currents initiated by steps -40 to 0 mV with a protocol which omitted the first step (Figure 4, top) . In this protocol, the last conditioning pulse was followed by return to a post-conditioning potential of -40 mV. Figure 4A compares contractions and currents recorded from a normal myocyte in the absence and presence of 300 µM amrinone. Amrinone had no effect on the magnitude of contraction although it decreased inward current. Figure 4B presents mean data which show that amrinone had no inotropic effect in normal myocytes activated with this protocol. However, amrinone continued to exert an inhibitory effect on I Ca-L ( Figure 4C ). Figure 4D shows that amrinone had no effect on contraction in a CM myocyte, but decreased I Ca-L . Mean data demonstrate that amrinone had no significant effect on contraction in CM myocytes, but significantly decreased I Ca-L (Figures 4E and F) . Thus, the lack of inotropic effect of amrinone on low gain CICR was not related to the order of activation of contractions. In the next set of experiments we examined the effects of amrinone when steps to 0 mV were made from a post-conditioning potential to -60 mV ( Figure   5 , top). Figure 5A shows recordings of contractions and currents in a normal myocyte in the absence and presence of 300 µM amrinone. Amrinone increased the amplitude of contraction initiated by a step from -60 to 0 mV and decreased inward current ( Figure 5A ). Figure 5B and C shows mean data for amplitudes of contraction and current densities recorded in normal myocytes. With this protocol, amrinone caused a significant increase in contraction in normal myocytes, despite continued inhibition of I Ca-L ( Figure 5B and C). However, with the same voltage clamp protocol, amrinone still did not exert a positive inotropic effect in CM myocytes, although inhibition of I Ca-L persisted ( Figure 5D , E and F). These data suggest that the inotropic This article has not been copyedited and formatted. The final version may differ from this version. However, when the post-conditioning potential was -60 mV ( Figure 6C ), a marked positive inotropic effect of amrinone appeared over a wide range of test potentials. This effect was accompanied by inhibition of I Ca-L , again with no apparent shift in voltage-dependence ( Figure   6D ). These data show that amrinone can exert a prominent positive inotropic effect over a wide range of test potentials in normal myocytes, but only when steps are made from negative membrane potentials. Furthermore, the effects of amrinone cannot be attributed to shifts in voltage-dependence of either contraction or current. currents recorded in a CM myocyte in the absence and presence of amrinone. Figure 10C shows that the mean amplitudes of contractures and integrals of Na + -Ca 2+ exchange currents were not significantly different in myocytes from CM hearts before and after exposure to amrinone. Thus, amrinone increased SR Ca 2+ stores in normal but not CM myocytes.
Inhibition of PDE by amrinone would be expected to promote phosphorylation of protein targets only if there is adequate production of cAMP in the cell. Thus the absence of a positive inotropic effect of amrinone may indicate that cAMP production is inadequate in CM myocytes.
To investigate this, we used forskolin to stimulate adenylyl cyclase and thus stimulate cAMP production in myocytes from CM heart. We selected a low concentration forskolin (0.3 µM) which does not, by itself, cause a significant increase in contraction (Feldman et al, 1987) . Then, we determined whether amrinone (300 µM) could increase contraction in CM myocytes in the presence of forskolin. The protocol is shown at the top of Figure 11 . Figure 11A shows representative traces of contraction (top) and current (bottom) recorded from a CM myocyte in response to a test step from -60 to 0 mV. Figure 11B demonstrates that 0.3 µM forskolin had little effect on magnitudes of either inward current or contraction activated by voltage steps from -60 mV. However, when 0.3 µM forskolin was added in combination with amrinone, contraction increased markedly in the CM myocyte ( Figure 11C ). Mean contraction-voltage and current-voltage curves are shown in figures 11D and E. These data show that a low concentration of forskolin had no significant effect on either contraction or current at any voltage examined. However, in the presence of forskolin, amrinone significantly increased the amplitudes of contractions ( Figure 11D ). Interestingly, amrinone plus forskolin had no significant effect on the magnitude of inward current ( Figure 11E ). Thus, minimal stimulation of This article has not been copyedited and formatted. The final version may differ from this version. In the present study we found that amrinone selectively increased contractions initiated by voltage steps from negative membrane potentials in normal hamster myocytes. We previously reported a similar selectivity for contractions initiated from membrane potentials near the resting potential in guinea pig ventricular myocytes (Xiong et al., 2001) . Interestingly, earlier studies demonstrating the positive inotropic effects of amrinone in in vitro cardiac muscle were conducted in multicellular preparations, where contractions were activated by action potentials triggered from the resting potential (Rosenthal and Ferrier, 1982; Kondo et al., 1983;  This article has not been copyedited and formatted. The final version may differ from this version. Malecot et al., 1985; Morner and Wolfart, 1990) . In contrast, our present study and our earlier study (Xiong et al., 2001) demonstrate that amrinone has virtually no effect on low gain CICR A central finding in the present study is that amrinone can increase high-gain CICR in normal myocytes, but these effects are absent in CM myocytes where high gain CICR is depressed (Howlett et al., 1999) . The mechanisms underlying depression of high gain CICR and the lack of a stimulatory effect of amrinone in myocytes from CM animals are not certain.
However, cAMP content is significantly reduced in CM hamster hearts (Wikman-Coffelt et al., 1986) . We have shown previously that high-gain CICR is promoted by the cAMP-PKA pathway (Ferrier et al., 1998; Ferrier and Howlett, 2003; Richard et al., 2004) . Thus, lower levels of cAMP in CM myocytes might lead to weaker activation of high-gain CICR. A reduction in cAMP levels in CM myocytes might result through reduced synthesis or greater degradation.
The lack of effect of amrinone suggests that enhanced degradation is not responsible for depression of high-gain CICR. On the other hand, reduced synthesis of cAMP would explain the lack of effect of amrinone in CM myocytes. Indeed, a low concentration of forskolin, which did not in itself increase contraction, restored the stimulatory effect of amrinone in CM myocytes.
Thus, it is likely that the absence of high gain CICR in CM myocytes reflects a reduction in basal cAMP production in CM myocytes. Interestingly, reduced synthesis of cAMP also has been shown to underlie reduced sensitivity and maximum effect of PDE-III inhibitors in trabeculae from hearts of patients in end-stage heart failure (Feldman et al., 1987; Bohm et al., 1988) . As CM hamsters eventually develop heart failure (Jasmin and Proschek, 1982; Hunter et al., 1984) , our results suggest that a defect in the cAMP-PKA pathway is present before the onset of overt failure, and therefore may contribute to development of failure.
This article has not been copyedited and formatted. The final version may differ from this version. In summary, our results demonstrate that amrinone selectively enhances high gain CICR in normal hamster myocytes, but is not able to restore high gain CICR, which is depressed in myocytes from CM hamsters, except in the presence of forskolin which stimulates adenylyl cyclase. Further, the positive inotropic effect of amrinone in normal myocytes cannot be attributed to effects on I Ca-L , which is inhibited in hamster myocytes by this drug. However, the positive inotropic effect may reflect increased SR Ca 2+ stores, as increased SR stores accompanied the positive inotropic effect in normal myocytes but were absent in CM myocytes.
Interestingly, loss in sensitivity to PDE-III inhibitors has been observed in end-stage heart failure in humans (Feldman et al., 1987; Bohm et al., 1988) . As the loss of sensitivity to PDE-III inhibitors in CM hamster myocytes occurred prior to the onset of heart failure, our results suggest that this defect may contribute to the development of heart failure in these animals.
This article has not been copyedited and formatted. The final version may differ from this version. recorded from a CM myocyte illustrate that amrinone had no effect on the magnitude of contraction but decreased the amplitude of inward current. Panels E and F. In CM myocytes amrinone did not have a significant effect on amplitudes of contraction, but caused a significant decrease in the amplitudes of peak I Ca-L . Denotes significantly different from control in the absence of drug (p<0.05); n = 9 -11 normal, and 4 -11 CM myocytes. Step -60 to -40 mV
Step -40 to 0 mV 
